Perrigo (PRGO) Change in Acquisitions & Divestments (2015 - 2017)
Perrigo (PRGO) posted quarterly Change in Acquisitions & Divestments of $2.2 billion for Q3 2017, up 2802.7% quarter-over-quarter from -$81.4 million in Q2 2015.
Perrigo (PRGO) Change in Acquisitions & Divestments (2015 - 2017) Analysis & Trends
Perrigo (PRGO) has reported Change in Acquisitions & Divestments for 2 consecutive years, with $2.2 billion the latest figure, recorded in Q3 2017.
- In Q3 2017, Change in Acquisitions & Divestments changed N/A year-over-year to $2.2 billion; the TTM figure through Dec 2018 stood at $2.2 billion (up 3.84% YoY), while the FY2017 annual figure was $2.2 billion, changed N/A from the prior year.
- Change in Acquisitions & Divestments climbed to $2.2 billion in Q3 2017 per PRGO's latest filing, from -$81.4 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $2.2 billion in Q3 2017 and bottomed at -$81.4 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 2.20 Bn |
| Sep 30, 2017 | 2.20 Bn |
| Jun 27, 2015 | -81.40 Mn |
| Jun 27, 2015 | -81.40 Mn |